NCT00930306 - AZD2066 Cocktail Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions

Chronic Pain

Interventions

DRUG

AZD2066

12 doses, Given as capsule, 2 mg \& 8 mg

DRUG

Caffeine

2 doses, Given as Tablet, 2x50 mg

DRUG

Tolbutamide

2 doses, Given as Tablet, half of 500 mg

DRUG

Omeprazole Tablet, 20 mg

2 doses, Given as Tablet, 20 mg

DRUG

Midazolam Tablet, 7.5 mg

2 doses, Given as Tablet, 7.5 mg

Trial Locations (2)

Research Site, London

Research Site, Manchester